Uni-Infusion Injection (L-Aspartic Acid-L-Ornithine)
L-Ornithine-L-Aspartate 500mg
Solution · Prescription medication
Korea Union Pharmaceutical Co., Ltd.
MFDS item code 200101499 · Notified 2001.04.26
Detoxification treatment for severe liver disease (hepatic encephalopathy)
This medication is used to treat hepatic encephalopathy caused by severe liver disease, which includes symptoms ranging from pre-coma to coma. Hepatic encephalopathy is a condition in which liver function is severely impaired, leading to toxins affecting the brain. This medicine helps improve these symptoms and aids in the recovery of the patient's condition. Therefore, it is used for the treatment of hepatic encephalopathy in patients with severe liver disease.
For hepatic encephalopathy (including pre-coma and coma), L-Aspartic Acid-L-Ornithine can be mixed up to 40 g (8 ampoules) in appropriate intravenous fluids and administered as a drip infusion daily. The dosage may be adjusted appropriately according to the symptoms.
This medication is in a glass ampoule and can have glass fragments enter the solution when opening the container, so it should be cut carefully to minimize glass particles. Extra caution should be taken especially when used for children or the elderly. This medication should not be used in patients with certain conditions. For example, it should not be administered to patients with lactate acidosis, methanol poisoning, sensitivities to fructose or sorbitol, certain enzyme deficiencies, and severely impaired renal function. Additionally, this medication contains sodium metabisulfite, which may cause allergic reactions. Patients with asthma or those who are sensitive to sulfites may experience severe allergic reactions, so it should be used with caution. When using this medication, there may occasionally be a feeling of warmth in the back of the head or nausea, and gastrointestinal discomfort or vomiting may occur. In case of high dosages, urea levels in the blood or urine should be monitored to check the body condition. Patients with weakened liver function should adjust the infusion speed to reduce discomfort or vomiting. This medication should be administered slowly intravenously, as rapid infusion may lead to side effects. When storing it, it should be kept in a secure place out of reach of children and should not be transferred from its original container to another container. This will help maintain the quality of the medication and prevent misuse.
Asthma attack
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to light, so it should be stored in a light-protected tightly sealed container. Additionally, the medication should be stored at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication over a long period.
[For domestic use, for export 1] Colorless to light yellow solution contained in a brown ampoule
5 ampoules/box [(10 milliliters/ampoule)], 10 ampoules/box [(10 milliliters/ampoule)], 25 ampoules/box [(10 milliliters/ampoule)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
L-Ornithine-L-Aspartate 500mg
Solution · Prescription medication
Korea Union Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Prescription medication
Hanwha Pharm Co., Ltd.
L-Ornithine-L-Aspartate 3g
OTC medication
Hanwha Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 5g
Injections · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Injections · Prescription medication
Daewon Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 500mg
Prescription medication
Daehan Pharmaceutical Co., Ltd.
L-Ornithine-L-Aspartate 15000mg
Solution · OTC medication
Joah Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.